Name: Gross Profit Margin

Definition: Gross profit margin shows how much profit the company keeps from each dollar of sales after covering the direct cost of making its products or delivering services. High margins suggest strong pricing power or efficient production. Shrinking margins might mean rising costs or tougher competition eating into profits.

Interpretation:
• In '2021', ABCL's gross profit margin was 87.9%, showing profitability after production and operational costs. Industry average for Pharmaceuticals and Biotechnology in '2021' stood at 87.9%.
• In '2022', ABCL's gross profit margin was 86.3%, showing profitability after production and operational costs. The decline from '2021' may indicate some operational or financial challenges. Industry average for Pharmaceuticals and Biotechnology in '2022' stood at 86.3%. Industry average declined by 1.6% from previous year.
• In '2023', ABCL's gross profit margin was 100.0%, showing profitability after production and operational costs. The increase since '2022' reflects strengthening financial performance. Industry average for Pharmaceuticals and Biotechnology in '2023' stood at 100.0%. Industry average increased by 13.7% compared to previous year.
• In '2024', ABCL's gross profit margin was 100.0%, showing profitability after production and operational costs. The figure remained stable compared to '2023'. Industry average for Pharmaceuticals and Biotechnology in '2024' stood at 100.0%. Industry average remained unchanged from prior year.
Overall, ABCL's gross profit margin has steadily improved over the past 4 years.

Formula: Gross Profit Margin = (Revenue - COGS) / Revenue

Good Range: Often 20%-60% depending on industry.